About Us
We are pursuing a dual path strategy involving entry into the follow on biologics arena (also known as biosimilars, biogenerics and biologics) and advancing our proprietary protein platform into niche markets with unmet needs.
Insmed Incorporated is a development stage company with extensive expertise in protein drug development. We have a state-of-the art FDA-approved biologic commercial manufacturing facility in Boulder, Colorado and a corporate office in Richmond Virginia.
We are pursuing a dual path strategy involving entry into the follow on biologics arena (also known as biosimilars, biogenerics and biologics) and advancing our proprietary protein platform into niche markets with unmet needs. In the follow on biologics field Insmed is developing a robust pipeline of products targeted for markets in anemia, neutropenia and autoimmune diseases. In addition, on the proprietary protein front Insmed's lead product, the FDA-approved IPLEX™, is being studied as a treatment for several serious medical conditions such as Myotonic Muscular Dystrophy, HIV-associated Adipose Redistribution Syndrome and Retinopathy of Prematurity.
Focusing on Markets with Unmet Needs
Some of the biggest advances in science over the last century have occurred in the development of pharmaceuticals. Diseases which once terrified millions upon millions of people in the world have been held in check or in some cases completely eradicated because of the great work of some of the world's pharmaceutical corporations.
